Operating Lease, Liability, Current in CNY of NovaBridge Biosciences from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD and CNY
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
NovaBridge Biosciences quarterly Operating Lease, Liability, Current history and change rate from Q4 2019 to Q4 2023.
  • NovaBridge Biosciences Operating Lease, Liability, Current for the quarter ending 31 Dec 2023 was ¥21,890,000.000, a 8.64% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (CNY)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Operating Lease, Liability, Current (CNY)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 21,890,000 -2,071,000 -8.6% 31 Dec 2023 20-F 30 Apr 2024
Q4 2022 23,961,000 -6,708,000 -21.9% 31 Dec 2022 20-F 30 Apr 2024
Q2 2022 42,527,000 30 Jun 2022 6-K 10 Nov 2022
Q4 2021 30,669,000 +22,611,000 +2.8% 31 Dec 2021 20-F 01 May 2023
Q4 2020 8,058,000 +1,251,000 +18.4% 31 Dec 2020 20-F 29 Apr 2022
Q3 2020 8,001,000 30 Sep 2020 6-K 05 Feb 2021
Q4 2019 6,807,000 31 Dec 2019 20-F 28 Apr 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.